Viewing nowCombinationExfor Tablet 5/160 mg
Amlodipine Besylate 6.94mg · Valsartan 160mg
Tablet · Prescription medication · Combination
KS Pharmaceutical Co., Ltd.

MFDS item code 201309094 · Approved 2013.08.30 · Insurance code 059000030
Treatment of essential hypertension not controlled with monotherapy
This medication is used in patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with either amlodipine or valsartan. It effectively controls blood pressure, helping to reduce the risk of complications associated with hypertension.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 mg or valsartan 80 mg. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 mg or valsartan 160 mg. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 10 mg or valsartan 160 mg, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Caution should be exercised when increasing the dose.
Use of this medicine is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.
This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this drug's active ingredient or similar components, women who are pregnant or may become pregnant, lactating women, and those with severe renal or hepatic dysfunction should not use this medication. Patients who are sodium or volume depleted, those with hyperkalemia, renal artery stenosis, recent kidney transplant recipients, individuals with a history of angioedema, and those with heart failure or post-myocardial infarction should use this medication with caution and closely monitor their condition. Side effects such as dizziness, headache, edema, and hypotension may occur during treatment; if unusual symptoms arise, immediate consultation with healthcare professionals is necessary. Caution is advised when driving or operating machinery, as dizziness or fatigue may occur. There may be drug interactions, especially with potassium supplements, diuretics, certain anti-inflammatory drugs (NSAIDs), simvastatin, and specific antifungal or antiviral agents, so it is important to inform your doctor or pharmacist if you are taking any of these. It is best for women who are pregnant or breastfeeding to avoid using this drug; those planning a pregnancy or suspecting they could be pregnant should consult healthcare professionals. Use in children under 18 is not recommended due to insufficient safety and efficacy data. In case of overdose, severe hypotension or cardiovascular issues may arise, so it is crucial to adhere to the prescribed dosage and contact medical assistance immediately if overdosed. Regular blood pressure and renal function testing should be done while taking this medication, and any unusual symptoms should be reported to healthcare professionals immediately.
nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, orthostatic dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, throat and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, pruritus, joint swelling, low back pain, arthritis, muscle spasm, lethargy, polyuria, nocturia, erectile dysfunction, edema, scrotal edema, facial swelling, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenic purpura, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremor, sensory decrease, taste disturbance, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, phototoxic reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary dysfunction, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, nervous hypersensitivity, sensory decrease, Stevens-Johnson syndrome, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. The storage temperature must be maintained between 1 and 30 degrees Celsius room temperature. Proper storage will help maintain the drug's efficacy and prevent degradation.
Dark yellow oval film-coated tablets
28 tablets/box [14 tablets/Alu-Alu X 2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.94mg · Valsartan 160mg
Tablet · Prescription medication · Combination
KS Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.